Story perspectives

Justice Department, DEA Reach $50 Million Walmart Opioid Settlement

8/31/2026

Summary

Walmart Settles Opioids

The U.S. Justice Department and DEA secured a $50 million settlement with Walmart over opioid prescription fills.
The government alleged Walmart filled invalid prescriptions and ignored refusal-to-fill reports since June 26 2013.
Compliance directors reportedly prioritized sales and patient awareness over reviewing refusal-to-fill forms.
Pharmacists allegedly filled prescriptions from known pill-mill prescribers or with red-flag drug combinations.
Walmart must create a hotline for reporting illegal dispensing and monitor dispensing patterns and suspect prescribers.

Summary

Walmart Small Settlement

The $50 million settlement is far smaller than Walmart’s 2022 $1.3 billion opioid settlement.
Potential civil penalties could have reached billions, up to $67,627 per unlawful prescription.
The agreement caps penalties for each unreported suspicious order at $15,691.
Kroger’s 2023 settlement of $1.2 billion illustrates broader industry opioid litigation costs.
CVS and Walgreens each paid multibillion-dollar settlements, highlighting systemic financial exposure.

History

Historical Context

After the FDA approved Purdue Pharma’s controlled-release OxyContin in December 1995, the company launched a nationwide marketing push in 1996 that helped lift sales to about $3 billion by 2001 and spurred a surge in opioid prescriptions. The Justice Department’s 2020 lawsuit against Walmart for lax pharmacy screening culminated in a $50 million settlement in 2024, echoing earlier actions against retailers.

1 of 3

Walmart Settles Opioids

The U.S. Justice Department and DEA secured a $50 million settlement with Walmart over opioid prescription fills.
The government alleged Walmart filled invalid prescriptions and ignored refusal-to-fill reports since June 26 2013.
Compliance directors reportedly prioritized sales and patient awareness over reviewing refusal-to-fill forms.
Pharmacists allegedly filled prescriptions from known pill-mill prescribers or with red-flag drug combinations.
Walmart must create a hotline for reporting illegal dispensing and monitor dispensing patterns and suspect prescribers.

1 / 3